Expression of Pro-Fibrotic Factors in Cardiac Tissue of Wistar and Sprague–Dawley Rats during the Development of Chronic Kidney Disease
暂无分享,去创建一个
A. Bagrov | N. Agalakova | I. V. Romanova | O. V. Nadei | E. Mikhailova | А. А. Piankov | I. Ershov | M. V. Galagudza
[1] Carmen Llorens-Cebrià,et al. Endothelin Receptor Antagonists in Kidney Disease , 2023, International journal of molecular sciences.
[2] A. Bagrov,et al. Fli1 and Tissue Fibrosis in Various Diseases , 2023, International journal of molecular sciences.
[3] J. Townend,et al. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations , 2022, Journal of Human Hypertension.
[4] W. Nadruz,et al. Endothelial and Vascular Smooth Muscle Dysfunction in Hypertension. , 2022, Biochemical pharmacology.
[5] M. Yaqoob,et al. Cardiac metabolic remodelling in chronic kidney disease , 2022, Nature Reviews Nephrology.
[6] A. Kriegel,et al. Comparison of the Surgical Resection and Infarct 5/6 Nephrectomy Rat Models of Chronic Kidney Disease. , 2022, American journal of physiology. Renal physiology.
[7] L. A. Romanova,et al. Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia , 2022, International journal of molecular sciences.
[8] Kartheek Garikapati,et al. Uraemic Cardiomyopathy: A Review of Current Literature , 2021, Clinical Medicine Insights. Cardiology.
[9] B. Machado,et al. Distinct cardiovascular and respiratory responses to short-term sustained hypoxia in juvenile Sprague Dawley and Wistar Hannover rats , 2020, Autonomic Neuroscience.
[10] J. Zicha,et al. Contribution of selected vasoactive systems to blood pressure regulation in two models of chronic kidney disease. , 2020, Physiological research.
[11] P. Jiruska,et al. Strain differences in intraluminal thread model of middle cerebral artery occlusion in rats. , 2019, Physiological research.
[12] E. Heinzle,et al. Hepatocytes of Wistar and Sprague Dawley rats differ significantly in their central metabolism , 2018, Journal of cellular biochemistry.
[13] M. Saracyn,et al. Role of Nitric Oxide Pathway in Development and Progression of Chronic Kidney Disease in Rats Sensitive and Resistant to its Occurrence in an Experimental Model of 5/6 Nephrectomy , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[14] C. Calhau,et al. High-fat diet-induced obesity Rat model: a comparison between Wistar and Sprague-Dawley Rat , 2016, Adipocyte.
[15] K. Becker,et al. Variation in Behavioral Deficits and Patterns of Recovery After Stroke Among Different Rat Strains , 2014, Translational Stroke Research.
[16] S. Haller,et al. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. , 2012, American journal of hypertension.
[17] R. Raman,et al. Factors influencing rat survival in a warm renal ischemia model: time to adapt the protocols. , 2011, Transplantation proceedings.
[18] B. Walker,et al. Rat Strain Differences in Pulmonary Artery Smooth Muscle Ca2+ Entry Following Chronic Hypoxia , 2009, Microcirculation.
[19] D. Watson,et al. Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. , 2009, American journal of physiology. Renal physiology.
[20] Larisa V. Fedorova,et al. Marinobufagenin Stimulates Fibroblast Collagen Production and Causes Fibrosis in Experimental Uremic Cardiomyopathy , 2007, Hypertension.
[21] Deepak Malhotra,et al. Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy , 2006, Hypertension.
[22] G. Kundt,et al. Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats--influence of sex, strain, and surgical procedure. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[23] S. Nishijima,et al. Morphological differences in cardiovascular anomalies induced by bis‐diamine between Sprague–Dawley and Wistar rats , 2005, Congenital anomalies.
[24] E. Lewis,et al. Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney model. , 1990, Kidney international.
[25] E. Kühn,et al. Endocrine differences between the Wistar and Sprague-Dawley laboratory rat: influence of cold adaptation. , 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[26] C. Baylis,et al. DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains. , 2007, American journal of physiology. Renal physiology.
[27] J. Kriegsmann,et al. Temporary warm ischaemia, 5/6 nephrectomy and single uranyl nitrate administration--comparison of three models intended to cause renal fibrosis in rats. , 2001, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.